14 results
6-K
EX-1.1
SLGL
Sol-Gel Technologies Ltd
19 Apr 22
Open Market Sale Agreementsm
4:05pm
or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither
20-F/A
2021 FY
SLGL
Sol-Gel Technologies Ltd
7 Apr 22
Annual report (foreign) (amended)
4:06pm
pressure on health care costs in general, particularly prescription drugs, has become intense. As a result, there are increasingly high barriers to entry
6-K
EX-99.2
qplv6
6 Aug 20
Sol-Gel Technologies Reports Second Quarter 2020 Financial Results and Corporate Update
10:37am
6-K
EX-1.1
v1zmrt
14 Feb 20
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase
5:24pm
6-K
EX-1.1
8o6vn0nl996f 28i41n8
13 Jan 20
Current report (foreign)
12:00am
6-K
EX-1.1
i6r09dkqmyel18d
8 Aug 19
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares
4:03pm
6-K
EX-1.1
km7hx9q
31 May 19
Open Market Sale Agreementsm
5:25pm
20-F
6f7q 67jd
26 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next